Home Sitemap Contact Us HOME ABOUT Aims and Scope About the KJM General Information Editorial Board Best Pracitce Open Access Contact us BROWSE ARTICLES All issues Accepted Articles Ahead-of Print Articles Current Issue Most Read Articles Most Cited Articles Korean J Med Search Author Index EDITORIAL POLICY Research and Publication Ethics Peer Review Policy Preprints Policy Advertising Policy Data Archiving Policy Data Sharing Policy FOR CONTRIBUTORS Instructions for Authors Copyright Transfer Agreements Article-processing Charge E-Submission Notice : Undefined index: c in /home/virtual/kaim/ekjm/JATS/php_xml.php on line 4 TOOLS PDF Links PubReader ePub Link Notice : Undefined variable: _server in /home/virtual/kaim/ekjm/include/include.right.php on line 46 XML Download Notice : Use of undefined constant doi - assumed 'doi' in /home/virtual/kaim/ekjm/include/include.right.php on line 54 Notice : Use of undefined constant doi - assumed 'doi' in /home/virtual/kaim/ekjm/include/include.right.php on line 55 Full text via DOI Notice : Use of undefined constant pmcid - assumed 'pmcid' in /home/virtual/kaim/ekjm/include/include.right.php on line 61 Notice : Undefined index: slide in /home/virtual/kaim/ekjm/include/include.right.php on line 67 Download Citation Print Share : METRICS 1 Crossref 0 Scopus 20,020 View 335 Download Editorial Office 101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea Tel: +82-2-2271-6791 Fax: +82-2-790-0993 E-mail: [email protected] Copyright 2026 by The Korean Association of Internal Medicine.

Tesamorelin was also administered to patients with type 2 diabetes at doses of up to 2mg/daily
"People don't always appreciate this," says Rubino
Stable Gastric Pentadecapeptide BPC 157, Roberts Cytoprotection/Adaptive Cytoprotection (review)
[DOI] [PubMed] [Google Scholar] 97.Tzoulis P., Batavanis M., Baldeweg S
Positive results have been noted in many animal studies and some human studies using bilberry for macular degeneration as well as other eye disorders including diabetic retinopathy, retinitis pigmentosa, glaucoma, and cataracts (Fursova 2005